Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in progressive multiple sclerosis
NL-OMON37668Phase 3Not yet recruiting
- Sponsor
- UZ Brussel
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Fluoxetine with Placebo (2 arms). Primary endpoints: Timed 25-Foot Walk and 9-Hole Peg Test. Planned start Jul 2012; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON37668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37668.